Kiora Pharmaceuticals, Inc. (KPRX)

NASDAQ: KPRX · Real-Time Price · USD

2.660

+0.040 (1.53%)

At close: Aug 21, 2026, 4:00 PM EDT

2.680

+0.020 (0.75%)

After-hours: Aug 21, 2026, 6:59 PM EDT

Kiora Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.08	8.7	3.79	2.45	5.96	7.85
Short-Term Investments	9.76	8.39	23	-	-	-
Cash & Short-Term Investments	16.84	17.09	26.79	2.45	5.96	7.85
Cash Growth	-18.52%	-36.22%	991.47%	-58.85%	-24.06%	562.47%
Accounts Receivable	1.09	1.52	0.6	-	-	-
Other Receivables	1.82	1.79	0.27	2.05	1.37	0.53
Receivables	2.91	3.32	0.87	2.05	1.37	0.53
Prepaid Expenses	1.52	1.34	2.04	0.23	0.34	0.61
Total Current Assets	21.26	21.75	29.71	4.74	7.68	8.99
Property, Plant & Equipment	0.36	0.38	0.06	0.11	0.17	0.28
Other Intangible Assets	-	-	-	0.12	0.14	0.17
Long-Term Deferred Charges	2.06	2.06	6.69	8.7	10.6	10.6
Other Long-Term Assets	0.09	0.06	0.03	0.05	0.08	0.09
Total Assets	23.78	24.25	36.48	13.71	18.68	20.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.22	1.06	0.42	0.21	1.01	0.16
Accrued Expenses	1.92	2.26	2.26	1.38	1.84	1.33
Current Portion of Leases	0.17	0.16	0.02	0.05	0.11	0.12
Current Income Taxes Payable	0.07	0.14	2.33	-	-	-
Other Current Liabilities	-	-	0.98	-	0.32	-
Total Current Liabilities	2.37	3.63	6.01	1.63	3.27	1.61
Long-Term Leases	0.16	0.2	0.03	0.06	-	0.09
Long-Term Unearned Revenue	1.25	1.25	-	-	-	-
Long-Term Deferred Tax Liabilities	0.1	0.1	0.49	0.78	0.69	0.8
Other Long-Term Liabilities	3.04	2.94	4.19	5.13	3.31	3.05
Total Liabilities	6.92	8.13	10.72	7.6	7.27	5.55

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.28	0.28	0.27	0.08	0.02	0
Additional Paid-In Capital	175.54	170.31	169.16	153.19	146.04	135.54
Retained Earnings	-158.71	-154.22	-143.38	-146.98	-134.46	-120.88
Comprehensive Income & Other	-0.26	-0.25	-0.28	-0.18	-0.18	-0.09
Total Common Equity	16.86	16.13	25.76	6.11	11.41	14.58
Shareholders' Equity	16.86	16.13	25.76	6.11	11.41	14.58
Total Liabilities & Equity	23.78	24.25	36.48	13.71	18.68	20.13

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	0.33	0.37	0.06	0.11	0.11	0.21
Net Cash (Debt)	16.51	16.72	26.73	2.35	5.86	7.65
Net Cash Growth	-18.43%	-37.46%	1038.72%	-59.93%	-23.37%	1150.70%
Net Cash Per Share	3.45	4.01	6.48	4.36	72.00	285.39
Filing Date Shares Outstanding	4.42	3.95	3	2.92	0.21	0.04
Total Common Shares Outstanding	4.43	3.76	3	0.86	0.2	0.04
Working Capital	18.89	18.12	23.7	3.1	4.41	7.38
Book Value Per Share	3.81	4.29	8.58	7.14	57.15	414.44
Tangible Book Value	16.86	16.13	25.76	5.99	11.26	14.41
Tangible Book Value Per Share	3.81	4.29	8.58	7.00	56.43	409.64
Machinery	-	0.01	0.01	0.01	0.15	0.16
Leasehold Improvements	-	0.11	-	-	0.02	0.02

SEC Filings: 10-K · 10-Q